採用
Benefits & Perks
•Healthcare
•401(k)
•Equity
•Gym
•Parental Leave
•Paid Time Off
•Healthcare
•401k
•Equity
•Gym
•Parental Leave
Required Skills
Market access strategy
Pricing and reimbursement
HTA submissions
Healthcare policy
Stakeholder engagement
Analytical skills
Cross-functional collaboration
At Regeneron, we are committed to redefining healthcare. Join our mission to ensure patients across Europe have access to life-changing therapies. As the Regional Access Lead for Rare Diseases (Europe Region), you will play a pivotal role in driving market access, pricing, and reimbursement strategies for our innovative portfolio of rare disease treatments.
This is an outstanding opportunity to develop healthcare policy, engage with key partners, and make a tangible impact on patients’ lives. Collaborating with global, regional, and local teams, you will lead initiatives that align with EU-wide healthcare systems and payer requirements, ensuring our therapies reach those who need them most.
In a typical day you will:
- Develop and implement comprehensive strategies tailored to rare diseases in the EU region, ensuring alignment with global and local objectives.
- Supervise EU healthcare policies, payer trends, and reimbursement frameworks to find opportunities and address challenges.
- Collaborate with cross-functional teams, including commercial, medical affairs, and HEOR, to ensure cohesive strategy execution.
- Adapt global market access tools to meet regional requirements and maintain consistency in product value propositions.
- Own the preparation and submission of HTA dossiers across EU countries, employing evidence-based approaches to secure reimbursement.
- Build and maintain positive relationships with payers, policymakers, and patient advocacy groups to drive access initiatives.
- Partner with medical affairs and in-country teams to align evidence generation plans with EU payer requirements.
- Coordinate advisory boards, conduct market research, and perform landscape assessments to advise strategic decisions.
This role might be for you if you:
- Are passionate about improving access to innovative therapies for rare diseases.
- Have a proven track record in pricing, reimbursement, and market access strategies across multiple EU countries.
- Excel at establishing relationships with diverse collaborators, including payers, policymakers, and patient advocacy groups.
- Are skilled at navigating the complexities of EU healthcare systems and reimbursement frameworks.
- Thrive in a collaborative, matrixed environment and can align cross-functional teams to achieve shared goals.
- Have strong analytical skills and can synthesize sophisticated data into actionable insights.
- Are fluent in English, with additional European languages being a plus.
To Be Considered:
You must have a minimum of 10 years of experience in the pharmaceutical industry, with at least 8 years in market access roles. An advanced degree in Life Sciences, Health Economics, or Business is preferred (master's or PhD desirable).
The ideal candidate will have demonstrated success in HTA submissions, pricing negotiations, and reimbursement approval processes in Europe, with experience leading rare disease product launches. Familiarity with EU healthcare policy shaping and multi-stakeholder engagement is a strong advantage.
Join us in driving access to life-changing therapies. Together, we can make a difference.
Apply today to be part of our mission.
Does this sound like you? Apply now to take your first step towards living the Regeneron Way! We have an inclusive culture that provides comprehensive benefits, which vary by location. In the U.S., benefits may include health and wellness programs (including medical, dental, vision, life, and disability insurance), fitness centers, 401(k) company match, family support benefits, equity awards, annual bonuses, paid time off, and paid leaves (e.g., military and parental leave) for eligible employees at all levels! For additional information about Regeneron benefits in the US, please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other countries’ specific benefits, please speak to your recruiter.
Please be advised that at Regeneron, we believe we are most successful and work best when we are together. For that reason, many of Regeneron’s roles are required to be performed on-site. Please speak with your recruiter and hiring manager for more information about Regeneron’s on-site policy and expectations for your role and your location.
Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveler community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. The Company will also provide reasonable accommodation to the known disabilities or chronic illnesses of an otherwise qualified applicant for employment, unless the accommodation would impose undue hardship on the operation of the Company's business.
For roles in which the hired candidate will be working in the U.S., the salary ranges provided are shown in accordance with U.S. law and apply to U.S.-based positions. For roles which will be based in Japan and/or Canada, the salary ranges are shown in accordance with the applicable local law and currency. If you are outside the U.S, Japan or Canada, please speak with your recruiter about salaries and benefits in your location.
Please note that certain background checks will form part of the recruitment process. Background checks will be conducted in accordance with the law of the country where the position is based, including the type of background checks conducted. The purpose of carrying out such checks is for Regeneron to verify certain information regarding a candidate prior to the commencement of employment such as identity, right to work, educational qualifications etc.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Compliance, Assistant Vice President
State Street · Hong Kong, China

Executive - EHS
Cushman & Wakefield · Chennai, India

Senior Director, Business Strategy and Operations
Gilead Sciences · United States - California - Foster City

Complex Claims Director - Auto & General Liability
AIG · 2 Locations

Director, Strategic Deal Development
ServiceNow · Waltham
About Regeneron

Regeneron
PublicFocused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations int...
10,001+
Employees
Westchester County
Headquarters
Reviews
3.2
5 reviews
Work Life Balance
2.0
Compensation
4.3
Culture
2.5
Career
3.5
Management
2.0
Pros
Good pay and benefits
Company events and perks
Great coworkers
Cons
Toxic management
Poor work-life balance
Micromanagement and lack of autonomy
Salary Ranges
1,037 data points
Junior/L3
Junior/L3 · Data Analyst
0 reports
$108,540
total / year
Base
-
Stock
-
Bonus
-
$92,259
$124,821
Interview Experience
5 interviews
Difficulty
2.2
/ 5
Duration
14-28 weeks
Offer Rate
60%
Experience
Positive 80%
Neutral 20%
Negative 0%
Interview Process
1
Application Review
2
Phone/Video Screen
3
Hiring Manager Interview
4
Panel Interview
5
Stakeholder Interview
6
Offer
Common Questions
Technical Knowledge
Behavioral/STAR
Past Experience
Presentation Skills
Culture Fit
News & Buzz
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS) - The Globe and Mail
Source: The Globe and Mail
News
·
4w ago
Regeneron bets added cholesterol benefit will help its obesity drug stand out - WTVB
Source: WTVB
News
·
5w ago
REGN Q4 Earnings Beat Estimates, Sales Rise on Eylea HD Growth - TradingView
Source: TradingView
News
·
5w ago
Regeneron beats quarterly profit estimates on Dupixent strength - Yahoo Finance
Source: Yahoo Finance
News
·
5w ago